{
  "meta": {
    "title": "Medicine_Mini_Test_5",
    "url": "https://brainandscalpel.vercel.app/medicine-mini-test-5-d059c2c9.html",
    "scrapedAt": "2025-11-30T07:32:44.081Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior wall myocardial infarction</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior wall myocardial infarction</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral wall myocardial infarction</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericarditis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents with chest pain, palpitations, and shortness of breath. His ECG shows ST-segment elevation in leads II, III, and aVF. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q253267",
      "question_audio": null,
      "question_video": null,
      "map_id": 253267,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Inferior wall myocardial infarction</strong> is diagnosed based on <strong>ST-segment elevation in leads II, III, and aVF</strong>, which correspond to the <strong>inferior</strong> aspect of the heart. This type of MI typically involves the <strong>right coronary artery (RCA)</strong>. Patients with inferior MI may present with <strong>hypotension</strong> and <strong>bradycardia</strong> due to <strong>vagal stimulation</strong> or <strong>right ventricular involvement</strong>.</p><p><strong>Option A: Anterior wall myocardial infarction</strong></p><p>An <strong>anterior wall MI</strong> involves the <strong>left anterior descending (LAD) artery</strong> and manifests with <strong>ST-segment elevation</strong> in <strong>leads V1-V4</strong>. In this case, there is no ST elevation in these leads, making anterior MI unlikely.</p><p><strong>Option B: Inferior wall myocardial infarction</strong></p><p><strong>ST-segment elevation in leads II, III, and aVF</strong> is a hallmark of <strong>inferior wall MI</strong>, which involves the <strong>right coronary artery (RCA)</strong>.</p><p>Symptoms like <strong>chest pain</strong>, <strong>palpitations</strong>, and <strong>shortness of breath</strong> are consistent with MI, and the ECG findings strongly support this diagnosis.</p><p>\"Posterior\" wall ischemia (almost always associated with lateral or inferior involvement) may be indirectly recognized by <em>reciprocal</em> ST depressions in leads V1 to V3 (thus constituting an ST elevation \"equivalent\" acute coronary syndrome).</p><p>When ischemic ST elevations occur as the earliest sign of acute infarction, they typically are followed within a period ranging from hours to days by evolving T-wave inversions and often by Q waves occurring in the same lead distribution.</p><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/1E4.jpg\"><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/1E1.jpg\"><p><strong>Option C: Lateral wall myocardial infarction</strong></p><p>A <strong>lateral wall MI</strong> affects leads <strong>I, aVL, V5, and V6</strong>. These leads correspond to the <strong>lateral aspect</strong> of the heart, often involving the <strong>left circumflex artery</strong>. In this case, the ST elevations are confined to <strong>II, III, and aVF</strong>, ruling out lateral MI.</p><p><strong>Option D: Pericarditis</strong></p><p><strong>Pericarditis</strong> typically causes <strong>diffuse ST-segment elevation</strong> across many leads (not localized to a specific region like in MI) and is accompanied by <strong>PR-segment depression</strong> in most leads. The lack of diffuse ST elevation and absence of PR depression make pericarditis unlikely in this case.</p><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/1E2.jpg\"><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/1E3.jpg\"><h3><strong>Key Takeaway:</strong></h3><ul><li><strong>ST-segment elevation in leads II, III, and aVF</strong> is diagnostic of an <strong>inferior wall myocardial infarction</strong>, most often involving the <strong>right coronary artery</strong>. Recognizing the ECG pattern is critical for prompt diagnosis and management.</li></ul><p>Topic: Cardiology, Myocardial Infarction, ECG Interpretation<br> Difficulty Level: May know<br> PYQ: NEET 2019</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine, page number.1828,2020</p>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Stable Angina</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-ST Elevation Myocardial Infarction (NSTEMI)</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">ST-Elevation Myocardial Infarction (STEMI)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male presents to the emergency department with severe chest pain lasting for 2 hours, radiating to the left arm. His ECG shows ST-segment depression in leads II, III, and aVF. Serum troponin I levels are elevated. Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q253268",
      "question_audio": null,
      "question_video": null,
      "map_id": 253268,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<h3><strong>Non-ST Elevation Myocardial Infarction (NSTEMI)</strong></h3><p>Option C.NSTEMI is characterized by <strong>elevated troponin levels</strong>, indicating myocardial necrosis without complete coronary artery occlusion. ECG findings include <strong>ST-segment depression or T-wave inversion</strong> but no ST elevation.</p><p>Option A.Stable angina typically occurs during exertion and resolves with rest or nitroglycerin. It is not associated with myocardial injury, so <strong>troponin levels remain normal</strong>. No ST-segment changes are seen beyond transient ischemic changes.</p><p>Option B.Unstable angina presents with chest pain at rest or minimal exertion, signaling a progression of coronary artery disease. However, <strong>troponin levels are not elevated</strong>, as myocardial necrosis has not occurred. ECG may show non-specific changes.</p><p>Option D.STEMI presents with <strong>ST-segment elevation</strong> on ECG, indicating complete coronary occlusion, along with elevated troponin. This patient shows ST depression, which is more suggestive of NSTEMI.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/2E.jpg\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/2E3.jpg\"><p>Following disruption of a vulnerable plaque, patients experience ischemic discomfort resulting from a reduction of flow through the affected epicardial coronary artery. The flow reduction may be caused by a completely occlusive thrombus (<em>right</em>) or subtotally occlusive thrombus (<em>left</em>). Patients with ischemic discomfort may present with or without ST-segment elevation. Of patients with ST-segment elevation, the majority (<em>wide red arrow</em>) ultimately develop a Q wave on the ECG (Qw MI), while a minority ( do not develop Q wave and, in older literature, were said to have sustained a <em>thin red arrow</em>) non-Q-wave MI (NQMI). <strong>Patients who present without ST-segment elevation are suffering from either unstable angina or a non-ST-segment elevation MI (NSTEMI) (</strong><strong><em>wide green arrows</em></strong><strong>), a distinction that is ultimately made based on the presence or absence of a serum cardiac biomarker such as CK-MB or a cardiac troponin detected in the blood.</strong> The majority of patients presenting with NSTEMI do not develop a Q wave on the ECG; a minority develop a Qw MI (<em>thin green arrow</em>).<img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/2E2.jpg\"><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: NEET 2021,INI CET 2020</p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine ,page number.2053</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate thrombolysis with streptokinase</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel, along with anticoagulation</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Elective coronary artery bypass graft (CABG) surgery</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation without pharmacological intervention</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old man with a history of hypertension presents with chest pain at rest for the last 2 hours. ECG shows ST-segment depression in multiple leads, and serum troponin levels are elevated. Which of the following is the most appropriate initial treatment strategy for this patient?</span></p>",
      "unique_key": "Q253269",
      "question_audio": null,
      "question_video": null,
      "map_id": 253269,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option B: Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel, along with anticoagulation</strong> <strong>DAPT (aspirin + P2Y12 inhibitor like clopidogrel)</strong> and anticoagulation (e.g., <strong>enoxaparin</strong> or <strong>unfractionated heparin</strong>) are the mainstays of treatment for NSTE-ACS. Early coronary angiography and revascularization (PCI) may be considered based on risk assessment.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/3E.jpg\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/3E1.jpg\"><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/3E2.jpg\"><p><strong>Option A: Immediate thrombolysis with streptokinase</strong> &ndash; Thrombolysis is not indicated for NSTE-ACS. It is used for <strong>ST-Elevation Myocardial Infarction (STEMI)</strong> when primary percutaneous coronary intervention (PCI) is unavailable.</p><p><strong>Option C: Elective CABG surgery</strong> &ndash; CABG is not the initial treatment for NSTE-ACS but is reserved for <strong>multi-vessel coronary disease</strong> found during angiography or severe coronary obstruction.</p><p><strong>Option D: Observation without pharmacological intervention</strong> &ndash; Incorrect. NSTE-ACS requires <strong>immediate pharmacological management</strong> to prevent progression to myocardial infarction and reduce mortality risk. Observation alone increases the chances of adverse outcomes.</p><h3><strong>Key to Remember / Mnemonics</strong></h3><ul><li><strong>\"MONA BASH for ACS\" mnemonic:</strong> Morphine, Oxygen, Nitroglycerin, Aspirin, Beta-blocker, ACE inhibitors, Statins, Heparin.</li><li><strong>DAPT + Anticoagulation = First-line therapy for NSTE-ACS</strong>.</li><li><strong>Thrombolytics are only used for STEMI</strong>, not NSTE-ACS.</li></ul><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: NEET 2021,INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine, page number:2050</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-blockers and nitrates</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blockers and nitrates</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspirin and beta-blockers</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis and statins</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the primary treatment strategy for Prinzmetal's Variant Angina (PVA)?</span></p>",
      "unique_key": "Q253270",
      "question_audio": null,
      "question_video": null,
      "map_id": 253270,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<h3><strong>Calcium channel blockers and nitrates</strong></h3><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/4E.jpg\"><p><strong>Option A: Beta-blockers and nitrates</strong> - While <strong>nitrates</strong> are part of the primary treatment, <strong>beta-blockers</strong> may have a <strong>variable response</strong> and are not the preferred option. Some beta-blockers can exacerbate vasospasm by unopposed alpha-adrenergic activity.</p><p><strong>Option B: Calcium channel blockers and nitrates</strong> - These two agents <strong>relieve coronary vasospasm</strong> and are the mainstay of therapy for PVA. Calcium channel blockers relax the smooth muscle in coronary arteries, reducing vasospasm, while nitrates help alleviate angina.</p><p><strong>Option C: Aspirin and beta-blockers</strong> - <strong>Aspirin</strong> can <strong>worsen ischemic episodes</strong> in PVA by altering prostacyclin synthesis. <strong>Beta-blockers</strong> are not routinely recommended.</p><strong>Option D: Thrombolysis and statins</strong> - Thrombolysis is not indicated in PVA, as it is not caused by a thrombus but by vasospasm. <strong>Statins</strong> can reduce long-term adverse events, but they are not part of acute management.<img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/4E1.jpg\"><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2052</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">History of ischemic stroke 2 months ago</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Uncontrolled hypertension (BP 170/110 mmHg)</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pregnancy</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Major surgery 3 weeks ago</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an absolute contraindication to thrombolytic therapy in a patient with acute myocardial infarction (AMI)?</span></p>",
      "unique_key": "Q253271",
      "question_audio": null,
      "question_video": null,
      "map_id": 253271,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<h4><strong>Option A: History of ischemic stroke 2 months ago</strong></h4><ul><li>A <strong>recent ischemic stroke (within the last 3 months)</strong> is classified as an <strong>absolute contraindication</strong> for thrombolysis.</li><li>Thrombolytic agents significantly increase the risk of <strong>intracranial hemorrhage</strong>, which is why a history of recent stroke prohibits their use.</li></ul><h4><strong>Option B: Uncontrolled hypertension (BP 170/110 mmHg)</strong></h4><ul><li><strong>Severe, uncontrolled hypertension</strong> (&ge;180/110 mmHg) is a <strong>relative contraindication</strong>, as it increases the risk of hemorrhagic stroke.</li><li>Blood pressure should ideally be <strong>controlled before thrombolytic therapy</strong>, using medications such as intravenous nitroglycerin or labetalol.</li></ul><h4><strong>Option C: P</strong>regnancy:Pregnancy  is not an absolute contraindication rather than it is relative contraindication.</h4><h4><strong>Option D: Major surgery 3 weeks ago</strong></h4><ul><li><strong>Recent major surgery</strong> is also a <strong>relative contraindication</strong> due to the risk of excessive bleeding at the surgical site. Thrombolysis is typically avoided for at least <strong>14 days</strong> post-surgery, but beyond this, it can be considered based on clinical necessity.</li></ul><h3><strong>Absolute Contraindications for Thrombolysis</strong></h3><p>Clear contraindications to the use of fibrinolytic agents include</p><ol><li>A history of cerebrovascular hemorrhage at any time,</li><li>a nonhemorrhagic stroke or other cerebrovascular event within the past year,</li><li>marked hypertension (a reliably determined systolic arterial pressure &gt;180 mmHg and/or a diastolic pressure &gt;110 mmHg) at any time during the acute presentation,</li><li>suspicion of aortic dissection, and</li><li>active internal bleeding (excluding menses).</li></ol><h3><strong>Relative Contraindications for Thrombolysis</strong></h3><ul><li>current use of anticoagulants (international normalized ratio &ge;2),</li><li>a recent (&lt;2 weeks) invasive or surgical procedure or</li><li>prolonged (&gt;10 min) cardiopulmonary resuscitation,</li><li>known bleeding diathesis,</li><li>pregnancy,</li><li>a hemorrhagic ophthalmic condition (e.g., hemorrhagic diabetic retinopathy),</li><li>active peptic ulcer disease, and</li><li>a history of severe hypertension that is currently adequately controlled</li></ul><p>Topic: Ischemic heart disease:STEMI<br> Difficulty Level: Must know<br> PYQ: NEET 2019,INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine,  page number.2059</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest X-ray</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">D-Dimer test</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Computed Tomography Pulmonary Angiography (CTPA)</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventilation-Perfusion (V/Q) scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents with sudden-onset dyspnea, pleuritic chest pain, and hemoptysis. She has a history of recent orthopedic surgery. On examination, her heart rate is 120 beats/min, respiratory rate is 28 breaths/min, and oxygen saturation is 89% on room air. Which of the following is the most appropriate initial diagnostic test for suspected pulmonary embolism?</span></p>",
      "unique_key": "Q253272",
      "question_audio": null,
      "question_video": null,
      "map_id": 253272,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option C: Computed Tomography Pulmonary Angiography (CTPA)</strong> -</p><ul><li><strong>CTPA</strong> is the <strong>gold standard diagnostic test</strong> for pulmonary embolism.</li><li>It provides direct visualization of emboli within the pulmonary arteries and is the <strong>first-line test</strong> in most cases with moderate-to-high clinical suspicion.</li></ul><p><strong>Option A: Chest X-ray</strong> -</p><ul><li>A chest X-ray is <strong>non-specific</strong> for diagnosing PE, though it can help rule out other causes of chest pain, such as pneumothorax or pneumonia.</li><li>Common findings in PE, like <strong>Hampton's hump</strong> or <strong>Westermark's sign</strong>, are rare and not diagnostic.</li></ul><p><strong>Option B: D-Dimer test</strong> -</p><ul><li>D-Dimer is useful as a <strong>screening tool</strong> in <strong>low-risk</strong> patients. A <strong>negative D-Dimer test</strong> can rule out PE in low-probability cases. However, it is <strong>non-specific</strong> and not useful in high-risk patients (such as this one with recent surgery).</li></ul><p><strong>Option D: Ventilation-Perfusion (V/Q) scan</strong>-</p><ul><li>A <strong>V/Q scan</strong> can be used in patients who cannot undergo CTPA (e.g., due to <strong>contrast allergy or renal failure</strong>).</li><li>However, it is less specific and typically reserved for situations where CTPA is contraindicated.</li></ul><p><strong>Key to Remember / Mnemonics</strong></p><ul><li><strong>\"PE = CTPA First\"</strong>:<ul><li><strong>C</strong>ontrast-enhanced CT <strong>P</strong>ulmonary <strong>A</strong>ngiography is the test of choice in most cases.</li><li>Use <strong>V/Q scan</strong> only if <strong>CTPA</strong> is <strong>not feasible</strong>.</li><li><strong>D-Dimer</strong> is helpful to <strong>rule out PE</strong> in <strong>low-risk</strong> patients but not in high-risk scenarios.</li></ul></li></ul><p><strong>Key features of Pulmonary embolism:</strong></p><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/6E1.jpg\"><p>Topic: Pulmonary embolism</p><p>Difficulty Level: Must know</p><p>PYQ: FMGE 2021,2023</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2097</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal response to exercise</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive test indicating myocardial ischemia</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Inconclusive result, repeat the test with pharmacologic stress</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Likely false-positive due to hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old man with a history of hypertension and exertional chest pain undergoes an exercise stress test. During the test, he develops horizontal ST-segment depression of 2 mm and chest discomfort at a low workload. Which of the following is the most appropriate interpretation of the test result?</span></p>",
      "unique_key": "Q253273",
      "question_audio": null,
      "question_video": null,
      "map_id": 253273,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<ul><li>The normal response to graded exercise includes progressive increases in heart rate and blood pressure.</li><li>Failure of the blood pressure to increase or an actual decrease with signs of ischemia during the test is an important adverse prognostic sign, since it may reflect ischemia-induced global LV dysfunction.</li><li>The development of angina and/or severe (&gt;0.2 mV) ST-segment depression at a low workload, i.e., before completion of stage II of the Bruce protocol, and/or STsegment depression that persists &gt;5 min after the termination of exercise increases the specificity of the test and suggests severe IHD and a high risk of future adverse events.</li></ul><p><strong>Option B: Positive test indicating myocardial ischemia</strong> - <strong>Horizontal ST-segment depression of &ge;0.2 mV (2 mm)</strong> during exercise, along with <strong>angina</strong>, is indicative of <strong>myocardial ischemia</strong>. This patient is likely experiencing exercise-induced ischemia due to coronary artery disease.</p><p><strong>Option A: Normal response to exercise</strong> -  A normal response to exercise does not involve <strong>ST-segment depression</strong> or the onset of chest discomfort. The patient&rsquo;s symptoms and ECG changes suggest a pathological finding.</p><p><strong>Option C: Inconclusive result, repeat the test with pharmacologic stress</strong> - The test is diagnostic for myocardial ischemia, and pharmacologic stress testing is not needed unless the patient cannot exercise adequately.</p><p><strong>Option D: Likely false-positive due to hypertension</strong> - Although hypertension can cause <strong>ST changes</strong>, the presence of <strong>typical chest pain</strong> and significant <strong>ST depression</strong> suggests a true positive result, indicating coronary ischemia.</p><h3><strong>Key Points from the Text</strong></h3><ul><li><strong>ST-segment depression</strong> of &ge;2 mm during exercise is a significant marker for myocardial ischemia.</li><li>Symptoms such as <strong>angina</strong> during the test strengthen the diagnostic value.</li><li><strong>Exercise tests are terminated</strong> if chest discomfort, significant ST changes, or dangerous arrhythmias occur.</li></ul><p>Topic: Ischemic heart disease:Chronic stable angina<br> Difficulty Level: May know<br> PYQ: INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2037</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate thrombolytic therapy</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Coronary arteriography to assess for revascularization</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Refer for CT angiography for coronary evaluation</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjust medical therapy and repeat stress testing in 3 months</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old man with chronic stable angina pectoris has been on optimal medical therapy but continues to experience severe angina. A stress test reveals moderate ischemia. Which of the following is the most appropriate next step in management?</span></p>",
      "unique_key": "Q253274",
      "question_audio": null,
      "question_video": null,
      "map_id": 253274,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option B: Coronary arteriography to assess for revascularization</strong> -</p><p><strong>Coronary arteriography</strong> is recommended for <strong>patients with chronic stable angina</strong> who continue to have severe symptoms despite optimal medical therapy.</p><p>Arteriography helps determine the presence and severity of coronary artery disease and identifies candidates for <strong>revascularization</strong> via <strong>percutaneous coronary intervention (PCI)</strong> or <strong>coronary artery bypass grafting (CABG)</strong>.</p><p>The <strong>ISCHEMIA trial</strong> supports this approach, showing that revascularization may improve <strong>symptom relief</strong> in symptomatic patients even though it doesn&rsquo;t significantly reduce the risk of death or myocardial infarction compared to medical therapy.</p><p><strong>Option A: Initiate thrombolytic therapy</strong> -</p><p><strong>Thrombolytic therapy</strong> is indicated for <strong>acute myocardial infarction with ST-segment elevation (STEMI)</strong>, not for chronic stable angina. Chronic angina requires assessment for coronary artery disease, not thrombolysis.</p><p><strong>Option C: Refer for CT angiography for coronary evaluation</strong> -</p><p><strong>CT angiography</strong> is a non-invasive option, but it is not the preferred tool when considering <strong>invasive revascularization</strong>, especially in symptomatic patients. CT angiography may be used for <strong>low- to moderate-risk patients</strong> where invasive procedures are not initially required.</p><p><strong>Option D: Adjust medical therapy and repeat stress testing in 3 months</strong> - <strong>Incorrect.</strong></p><p>Since the patient remains <strong>symptomatic despite optimal therapy</strong>, repeating stress testing without further action is not appropriate. In such cases, coronary arteriography is the correct next step to <strong>evaluate for obstructive coronary disease</strong> and <strong>revascularization options</strong>.</p><p><strong>Key Points from the Text</strong></p><ul><li><strong>Coronary arteriography</strong> is primarily indicated for:</li></ul><br><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/8E.jpg\"><p><strong>Mnemonic</strong></p><ul><li><strong>\"Symptomatic + Severe Angina = Arteriography for Revascularization\"</strong></li></ul><p>Topic: Ischemic heart disease:Coronary angiography</p><p>Difficulty Level: May know</p><p>PYQ: NEET 2021,INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2038</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Nifedipine</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-blockers</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Amlodipine</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Ranolazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57-year-old male with a history of hypertension and recent myocardial infarction (MI) is being considered for long-term management of his ischemic heart disease (IHD). Which of the following medications would improve survival in this patient?</span></p>",
      "unique_key": "Q253275",
      "question_audio": null,
      "question_video": null,
      "map_id": 253275,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option B: Beta-blockers</strong> -</p><p><strong>Beta-blockers</strong> reduce myocardial oxygen demand by <strong>lowering heart rate, blood pressure, and myocardial contractility</strong>.</p><p>In post-MI patients, beta-blockers have been shown to <strong>improve survival</strong>, reduce the risk of <strong>reinfarction</strong>, and lower the incidence of <strong>sudden cardiac death</strong>.</p><p><strong>Long-acting beta-blockers</strong> (e.g., <strong>metoprolol</strong> and <strong>carvedilol</strong>) are commonly used for their proven benefit in improving outcomes after MI.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/9E.jpg\"><p><strong>Relative contraindications </strong>include asthma and reversible airway obstruction in patients with chronic lung disease, atrioventricular conduction disturbances, severe bradycardia, Raynaud&rsquo;s phenomenon, and a history of mental depression.</p><p><strong>Side effects </strong>include fatigue, reduced exercise tolerance, nightmares, impotence, cold extremities, intermittent claudication, bradycardia (sometimes severe), impaired atrioventricular conduction, LV failure, bronchial asthma, worsening claudication, and intensification of the hypoglycemia produced by oral hypoglycemic agents and insulin.</p><p>Reducing the dose or even discontinuation may be necessary if these side effects develop and persist. Since sudden discontinuation can intensify ischemia, the doses <strong>should be tapered over 2 weeks.</strong> Beta blockers with relative <strong>&beta;1 -receptor specificity such as metoprolol and atenolol may be preferable in patients with mild bronchial obstruction and insulin-requiring diabetes mellitus.</strong></p><p><strong>Option A: Nifedipine</strong> -</p><p><strong>Nifedipine</strong> is a <strong>short-acting dihydropyridine calcium channel blocker</strong> that primarily causes <strong>vasodilation</strong>. However, it does not offer the same survival benefit post-MI as <strong>beta-blockers</strong>.</p><p>In fact, the use of short-acting nifedipine in patients with recent MI is discouraged due to the <strong>risk of reflex tachycardia</strong>, which can worsen myocardial ischemia.</p><p><strong>Option C: Amlodipine</strong></p><p><strong>Amlodipine</strong> is a long-acting dihydropyridine calcium channel blocker. While it is effective in treating <strong>hypertension</strong> and <strong>angina</strong>, it does not have the same <strong>mortality benefit</strong> in post-MI patients as beta-blockers.</p><p>Amlodipine may be useful in patients who cannot tolerate beta-blockers (e.g., those with asthma) but is not the preferred first-line agent for improving survival post-MI.</p><p><strong>Option D: Ranolazine</strong> -</p><p><strong>Ranolazine</strong> is used to treat <strong>chronic angina</strong> by inhibiting the <strong>late sodium current</strong>, which reduces myocardial calcium overload. However, it does not <strong>improve survival</strong> or prevent reinfarction and is used primarily for <strong>symptomatic relief</strong> in patients with refractory angina.</p><h3><strong>Key to Remember / Mnemonic</strong></h3><ul><li><strong>\"Beta-blockers Block MI Deaths\"</strong>: Beta-blockers <strong>reduce mortality</strong> and <strong>reinfarction</strong> rates post-MI by decreasing myocardial workload and improving cardiac outcomes. <br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/9E1.jpg\"></li></ul><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: NEET 2021,INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2041</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 Myocardial Infarction (MI)</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2 Myocardial Infarction (MI)</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4a Myocardial Infarction (MI)</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 5 Myocardial Infarction (MI)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with stable angina undergoes percutaneous coronary intervention (PCI) with stent placement. Within 12 hours after the procedure, his troponin levels are measured, and they are found to be elevated to 7 times the 99th percentile upper reference limit (URL). An ECG reveals new pathologic Q waves. Based on the definitions provided in the table for myocardial infarction, how should this event be classified?</span></p>",
      "unique_key": "Q253276",
      "question_audio": null,
      "question_video": null,
      "map_id": 253276,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option C: Type 4a MI</strong></p><ul><li><strong>Type 4a MI</strong> occurs in relation to PCI. The diagnostic criteria include:<ul><li><strong>Elevation of troponin &gt;5 times the 99th percentile URL</strong></li><li><strong>New pathologic Q waves</strong> or other ischemic changes</li><li>Imaging or angiographic findings indicating myocardial injury</li></ul></li></ul><p>Since this patient had <strong>troponin elevation of 7 times the 99th percentile URL</strong> and <strong>new Q waves</strong>, this fits the criteria for <strong>type 4a MI</strong>.</p><p><strong>Option A: Type 1 MI</strong></p><ul><li><strong>Type 1 MI</strong> refers to <strong>spontaneous myocardial infarction</strong> caused by <strong>atherosclerotic plaque rupture or erosion</strong> resulting in coronary thrombosis. This is not the correct classification since the myocardial injury in this case occurred after PCI.</li></ul><p><strong>Option B: Type 2 MI</strong></p><ul><li><strong>Type 2 MI</strong> is related to an <strong>imbalance between myocardial oxygen supply and demand</strong>, often seen in cases of severe anemia, tachycardia, or hypotension, rather than a direct procedural complication.</li></ul><p><strong>Option D: Type 5 MI</strong></p><ul><li><strong>Type 5 MI</strong> occurs after <strong>coronary artery bypass grafting (CABG)</strong> and requires a higher threshold for troponin elevation (&gt;10 times the 99th percentile URL).</li></ul><p><strong>Key to Remember / Mnemonic</strong></p><ul><li><strong>Type 4a = \"Angioplasty-associated MI\"</strong><ul><li>If MI occurs after <strong>PCI</strong>, it is classified as <strong>Type 4a</strong>.</li></ul></li></ul><br><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/10E2.jpg\"><br><img class=\"w-100\" style=\"height: auto; display: block; vertical-align: middle; border: 0;\" src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/10E1.jpg\"><p>Topic: Ischemic heart disease:STEMI</p><p>Difficulty Level: May know</p><p>PYQ: NEET 2019</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2057</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated cardiac markers</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Age &ge;65 years</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Current cigarette smoking</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Prior episodes of angina</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old male presents with chest pain and is diagnosed with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). His ECG shows 1 mm ST-segment depression, and he has two episodes of chest pain within the last 24 hours. His past medical history includes hypertension and diabetes mellitus, with known coronary artery disease (CAD). According to the TIMI risk score, which of the following is NOT a risk marker used to predict adverse cardiac events?</span></p>",
      "unique_key": "Q253277",
      "question_audio": null,
      "question_video": null,
      "map_id": 253277,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option C: Current cigarette smoking</strong></p><ul><li>Although cigarette smoking is a general <strong>CAD risk factor</strong>, it is <strong>NOT directly listed as a TIMI risk marker</strong> for NSTE-ACS. The TIMI score includes <strong>&ge;3 CAD risk factors</strong>, which may include smoking, but smoking alone is not an independent point in the score.</li></ul><p><strong>Option A: Elevated cardiac markers</strong></p><ul><li>Elevated <strong>troponin or CK-MB levels</strong> indicate myocardial injury and are included as one of the risk markers in the <strong>TIMI risk score</strong>.</li></ul><p><strong>Option B: Age &ge;65 years</strong></p><ul><li>Age over <strong>65 years</strong> is one of the risk factors included in the TIMI risk score to assess the risk of adverse cardiac events.</li></ul><p><strong>Option D: Prior episodes of angina</strong></p><ul><li><strong>History of prior angina</strong> is included as a risk marker in the TIMI risk score for NSTE-ACS.</li></ul><h3><strong>Key to Remember / Mnemonic</strong></h3><ul><li><strong>TIMI risk markers</strong>: \"A Senior Cardiologist Stressed Prior Cardiac Events\"<br> (Age &ge;65, Known CAD, ST deviation, Recent angina, Cardiac markers, &ge;2 CAD risk factors)</li></ul><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: NEET 2021,INI CET 2020</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2047</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Double vessel disease</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes mellitus</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired global LV function</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">B and C both</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following clinical settings is CABG preferred over PCI as the initial method of revascularization?</span></p>",
      "unique_key": "Q253278",
      "question_audio": null,
      "question_video": null,
      "map_id": 253278,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p>The clinical characteristics of each individual patient must be used to decide on the method of revascularization <strong>(e.g., LV function, diabetes, lesion complexity)</strong>. A number of randomized clinical trials have compared PCI and CABG in patients with <strong>multivessel CAD</strong> who were suitable technically for both procedures.</p><p>The redevelopment of angina requiring repeat coronary angiography and repeat revascularization is higher with PCI. This is a result of restenosis in the stented segment (a problem largely solved with drug-eluting stents) and the development of new stenoses in unstented portions of the coronary vasculature. It has been argued that PCI with stenting focuses on culprit lesions, whereas a bypass graft to the target vessel also provides a conduit around future culprit lesions proximal to the anastomosis of the graft to the native vessel.</p><p><strong>Option A: Double vessel disease</strong><br> CABG is not routinely preferred for <strong>double vessel disease</strong> unless it involves the <strong>proximal left anterior descending artery</strong> (LAD) or is associated with significant left ventricular dysfunction.</p><p><strong>Option B: Diabetes mellitus</strong><br> <strong>CABG</strong> is recommended in patients with <strong>diabetes mellitus</strong> and <strong>multivessel disease</strong> because it provides better long-term outcomes, including lower mortality and reduced need for repeat revascularization, compared to PCI.</p><p><strong>Option C: Impaired global LV function</strong><br> CABG is preferred over PCI in patients with <strong>impaired left ventricular (LV) function</strong> (ejection fraction &lt;50%) due to the benefits of bypass grafting in improving long-term survival and cardiac function.</p><p><strong>Option D: B and C both</strong><br> <strong>Correct</strong> - Both <strong>diabetes mellitus</strong> and <strong>impaired LV function</strong> are strong indications for CABG as the initial revascularization strategy, making this the most appropriate answer.</p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/12E.jpg\"><p>Topic: Ischemic heart disease:NSTEMI<br> Difficulty Level: May know<br> PYQ: NEET 2019</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2045</p>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Transfer immediately for PCI regardless of time</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer fibrinolytic therapy within 30 minutes of arrival</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Provide medical therapy and plan for outpatient follow-up</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait at the non-PCI-capable hospital until the PCI team is available</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old male with STEMI arrives at a non-PCI-capable hospital. The anticipated time from the first medical contact (FMC) to PCI is over 120 minutes. What is the appropriate initial management strategy based on current guidelines?</span></p>",
      "unique_key": "Q253279",
      "question_audio": null,
      "question_video": null,
      "map_id": 253279,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p><strong>Option B: Administer fibrinolytic therapy within 30 minutes of arrival</strong></p><ul><li>If the time from FMC to PCI exceeds <strong>120 minutes</strong>, <strong>fibrinolytic therapy</strong> is recommended to restore blood flow and limit infarct size.</li><li><strong>Fibrinolytic agents</strong> (e.g., alteplase, tenecteplase) should be given within <strong>30 minutes</strong> of the patient's arrival at the non-PCI-capable hospital to minimize ischemic damage.</li><li><strong>Class I, Level of Evidence: B</strong> supports fibrinolytic therapy in situations where PCI cannot be performed promptly.</li></ul><p><strong>Option A: Transfer immediately for PCI regardless of time</strong></p><ul><li>Although PCI is the preferred treatment for STEMI, <strong>time is critical</strong> for its effectiveness.</li><li>The <strong>door-to-device time</strong> at a PCI-capable hospital must be <strong>&le;120 minutes</strong> to offer optimal benefit. If the anticipated time is longer (as in this scenario), <strong>delaying treatment</strong> by transferring the patient increases the risk of myocardial injury and death.</li><li>As per guidelines, <strong>fibrinolysis</strong> should be administered promptly if timely PCI is not possible.</li></ul><p><strong>Option C: Provide medical therapy and plan for outpatient follow-up</strong></p><ul><li>STEMI is an acute emergency, and reperfusion therapy (either <strong>PCI or fibrinolysis</strong>) is essential for survival. Medical therapy alone (e.g., antiplatelet agents and beta-blockers) without reperfusion will not adequately reduce infarct size or prevent complications.</li><li><strong>Outpatient follow-up</strong> is appropriate after acute stabilization, not as the initial management of STEMI.</li></ul><p><strong>Option D: Wait at the non-PCI-capable hospital until the PCI team is available</strong></p><ul><li>Delaying reperfusion increases the risk of irreversible myocardial damage. Waiting until PCI becomes available, especially when transfer delays are expected, is not recommended.</li><li>Guidelines emphasize <strong>prompt fibrinolysis</strong> if PCI cannot be performed within <strong>120 minutes</strong> of FMC. Transfer for PCI is appropriate <strong>after fibrinolysis</strong>, particularly if there is evidence of <strong>failed reperfusion or reocclusion</strong>.</li></ul><p><strong>Summary:</strong></p><ul><li><strong>STEMI management</strong> aims to restore coronary blood flow promptly. PCI is the <strong>preferred strategy</strong>, but if the <strong>FMC-to-device time exceeds 120 minutes</strong>, <strong>fibrinolysis</strong> within 30 minutes is recommended.</li><li>After fibrinolysis, <strong>transfer</strong> to a PCI-capable center is still necessary for potential rescue PCI or further angiographic assessment.</li><li>Waiting or relying on medical therapy alone is not appropriate for acute STEMI.</li></ul><br><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/13E1.jpg\"><p>CABG, coronary artery bypass graft; DIDO, door-in-door-out; FMC, first medical contact; LOE, level of evidence.</p><p>Topic: Ischemic heart disease:STEMI</p><p>Difficulty Level: Must know</p><p>PYQ: NEET 2019</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2045</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer intravenous fluids</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer high-dose nitroglycerin</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Administration of furosemide</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate beta-blockers</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male with a history of inferior myocardial infarction presents with jugular venous distention, Kussmaul's sign, and hypotension. An ECG shows ST-segment elevation in the right-sided lead V4R. What is the most appropriate next step in the management of this patient?</span></p>",
      "unique_key": "Q253280",
      "question_audio": null,
      "question_video": null,
      "map_id": 253280,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<h4><strong>Option A: Administer intravenous fluids</strong></h4><ul><li>In <strong>right ventricular infarction (RVI)</strong>, the right ventricle fails to maintain forward flow due to impaired contractility. This causes <strong>reduced preload</strong> to the left ventricle and diminished cardiac output, which can lead to <strong>hypotension</strong>.</li><li>The <strong>primary goal</strong> in managing RVI is to <strong>restore right ventricular filling pressure</strong> with <strong>intravenous fluids</strong>, which helps optimize cardiac output and maintain blood pressure.</li><li>Careful monitoring is essential to avoid <strong>fluid overload</strong> since excessive volume can worsen RV dilation and impair left ventricular function due to <strong>ventricular interdependence</strong>.</li></ul><h4><strong>Option B: Administer high-dose nitroglycerin</strong></h4><ul><li>Nitroglycerin is a <strong>vasodilator</strong> that reduces <strong>preload</strong> and <strong>afterload</strong>. In patients with <strong>RVI</strong>, reducing preload can significantly worsen hypotension and compromise cardiac output, making nitroglycerin <strong>contraindicated</strong> in this setting.</li><li>Nitroglycerin is more appropriate in <strong>left ventricular infarction</strong> with pulmonary congestion but not in isolated RVI.</li></ul><h4><strong>Option C: Administration of furosemide</strong></h4><ul><li>Furosemide is a <strong>diuretic</strong> used to manage volume overload in conditions like <strong>heart failure</strong>. However, in the acute phase of RVI, where <strong>preload is already reduced</strong>, administering furosemide can further <strong>decrease filling pressures</strong> and exacerbate <strong>hypotension</strong>.</li><li>Furosemide should <strong>not be used</strong> in RVI unless there is clear evidence of <strong>fluid overload</strong> after adequate hemodynamic stabilization.</li></ul><h4><strong>Option D: Initiate beta-blockers</strong></h4><ul><li>While <strong>beta-blockers</strong> are beneficial in myocardial infarction by reducing myocardial oxygen demand, they should be <strong>used cautiously</strong> in patients with RVI, especially if <strong>hypotension</strong> or <strong>bradycardia</strong> is present.</li><li>Beta-blockers can <strong>worsen hypotension</strong> by reducing heart rate and contractility, which may further impair cardiac output in RVI. They should be <strong>deferred</strong> until the patient is hemodynamically stable.</li></ul><h3><strong>Key Points:</strong></h3><ul><li><strong>Right Ventricular Infarction (RVI)</strong> frequently occurs with <strong>inferior MI</strong> and presents with <strong>jugular venous distention</strong>, <strong>hypotension</strong>, and <strong>Kussmaul's sign</strong>.</li><li><strong>ECG changes</strong> in <strong>lead V4R</strong> are diagnostic for RVI.</li><li><strong>Intravenous fluid administration</strong> is the first-line treatment to maintain <strong>RV preload</strong> and stabilize cardiac output.</li><li><strong>Nitroglycerin</strong>, <strong>furosemide</strong>, and <strong>beta-blockers</strong> should be <strong>avoided</strong> or used with caution until the patient is stabilized.</li></ul><p>Topic: Cardiology, Myocardial Infarction, ECG Interpretation<br> Difficulty Level: Must know</p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2062</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticoagulant agent</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">NSAIDs</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform urgent coronary angiography</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitroglycerin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 58-year-old male presents 5 days after a myocardial infarction (MI) with pleuritic chest pain that radiates to the trapezius ridge. On examination, a pericardial friction rub is heard. Which of the following is the most appropriate next step in managing this patient?</span></p>",
      "unique_key": "Q253281",
      "question_audio": null,
      "question_video": null,
      "map_id": 253281,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000010
      ],
      "solution": "<p>This patient's presentation is consistent with <strong>post-MI pericarditis</strong>, a known complication that typically arises a few days after myocardial infarction. Pleuritic chest pain radiating to the <strong>trapezius ridge</strong> and a <strong>pericardial friction rub</strong> are hallmark features of pericarditis. Below is an analysis of the options provided:</p><h3><strong>Option A: Anticoagulant agent</strong></h3><ul><li>Although anticoagulation is essential in certain post-MI settings, such as managing <strong>left ventricular thrombi</strong> to prevent embolism, <strong>anticoagulants are contraindicated</strong> in acute pericarditis.</li><li>The use of anticoagulants in the setting of pericardial inflammation increases the risk of <strong>cardiac tamponade</strong>, which is life-threatening if blood accumulates in the pericardial space.</li></ul><h3><strong>Option B: NSAIDs</strong></h3><ul><li><strong>Non-steroidal anti-inflammatory drugs (NSAIDs)</strong>, such as <strong>aspirin or ibuprofen</strong>, are the recommended treatment for <strong>post-MI pericarditis</strong>. NSAIDs provide relief from <strong>inflammation and pain</strong> associated with pericarditis.</li><li><strong>Aspirin</strong> is often preferred after MI to avoid interfering with myocardial healing, but other NSAIDs such as ibuprofen may also be used in cases of uncomplicated pericarditis. The use of <strong>colchicine</strong> alongside NSAIDs has been shown to reduce recurrence rates of pericarditis.</li></ul> <h3><strong>Option C: Perform urgent coronary angiography</strong></h3><ul><li>While <strong>recurrent chest pain after an MI</strong> may necessitate coronary angiography to rule out <strong>reinfarction or ongoing ischemia</strong>, the <strong>trapezius radiation</strong> of pain and <strong>friction rub</strong> on auscultation point toward <strong>pericarditis</strong>, not ischemia. Thus, coronary angiography is unnecessary in this case.</li></ul><h3><strong>Option D: Nitroglycerin</strong></h3><ul><li>Nitroglycerin is effective for <strong>angina or ischemic chest pain</strong>, but it is <strong>not useful</strong> for <strong>pericarditis-related pain</strong>. It provides no benefit in addressing the inflammatory nature of the patient&rsquo;s symptoms.</li></ul><h3><strong>Key Points:</strong></h3><ol><li><strong>Post-MI pericarditis</strong> occurs within a few days of myocardial infarction and presents with <strong>pleuritic chest pain</strong> and <strong>pericardial friction rub</strong>.</li><li><strong>NSAIDs or aspirin</strong> are the treatments of choice, sometimes in combination with <strong>colchicine</strong> to prevent recurrence.</li><li><strong>Anticoagulants</strong> should be avoided in pericarditis because they increase the risk of <strong>pericardial tamponade</strong>.</li><li><strong>Coronary angiography</strong> is only needed if there is a strong suspicion of <strong>recurrent ischemia</strong>, not for pericarditis.</li><li><strong>Nitroglycerin</strong> is not effective for inflammatory chest pain caused by <strong>pericarditis</strong>.</li></ol><p><strong>Post-Myocardial Infarction Complications:</strong></p><img class=\"w-100\" style=\"height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d10ehao5y6v0v4.cloudfront.net/V3/LBNEETPG/QuizNov2024/MedicineMiniVI06112024/15E.jpg\"><p>Topic: Cardiology, Myocardial Infarction, ECG Interpretation<br> Difficulty Level: May know<br> </p><p><strong>Reference: </strong>Harrison's 21<sup>st</sup> edition principles of internal medicine page number.2064</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}